Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 12-2024 | 09-2024 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 408,741 | 30,851 | 0 |
| Marketable Securities | N/A | 59,544 | 124,780 | 0 |
| Receivables | N/A | 226 | 81 | 0 |
| TOTAL | $N/A | $476,010 | $158,693 | $0 |
| Non-Current Assets | ||||
| PPE Net | N/A | 827 | 490 | N/A |
| Other Non-Current Assets | 0 | 7,956 | 5,118 | 0 |
| TOTAL | $N/A | $8,783 | $5,608 | $N/A |
| Total Assets | $N/A | $484,793 | $164,301 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 4,341 | 3,557 | 0 |
| Accrued Expenses | N/A | 30,687 | 12,752 | 0 |
| Other current liabilities | N/A | N/A | 3,105 | 0 |
| TOTAL | $N/A | $35,712 | $19,580 | $0 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 2,381 | 323,358 | 0 |
| TOTAL | $N/A | $2,381 | $323,358 | $N/A |
| Total Liabilities | $N/A | $38,093 | $342,938 | $0 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 80,033 | 79,989 | N/A | N/A |
| Common Shares | N/A | 8 | N/A | 0 |
| Retained earnings | N/A | -317,770 | -222,523 | 0 |
| Other shareholders' equity | 0 | 36 | 348 | 0 |
| TOTAL | $N/A | $446,700 | $-178,637 | $0 |
| Total Liabilities And Equity | $0 | $484,793 | $164,301 | $0 |